2015-2019 French Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

September 2015 | 407 pages | ID: 204A18B8029EN
Venture Planning Group

Abstracts

Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $1,200. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearchcontains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

• Market shares of leading suppliers
• Business and technological trends in major markets
• Five-year test volume and sales forecasts
• Market shares of leading competitors
• Feature comparison of major analyzers
• Strategic profiles of leading market players and start-up firms developing innovative products
• Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

France Market Overview

• Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.
• Five-year test volume and sales projections.

Market Segmentation Analysis

• Five-year test volume and sales projections:
• Infectious Diseases - Forensic Testing
• Cancer - Paternity Testing/HLA Typing
• Genetic Diseases - Others
• A comprehensive analysis of the sequencing market by laboratory segment.
• Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

• Comparison of the major molecular diagnosticanalyzers.
• Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
• Worldwide listings of companies, universities and research centers developing new molecular diagnostictechnologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

• Abbott
• Affymetrix
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biokit
• BioMerieux
• Bio-Rad
• Biotest
• Cepheid
• CellMark Forensics Lab/Corp
• Decode Genetics
• Diadexus
• Eiken
• Elitech Group
• Enzo
• Exact Sciences
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• Illumina
• Kreatech/Leica
• Li-Cor Biosciences
• Monogram Biosciences
• Myriad Genetics
• Ortho-Clinical Diagnostics
• Perkin Elmer/Caliper
• Proteome Sciences
• Qiagen
• Roche
• Scienion
• Sequenom
• Shimadzu
• Siemens
• Sierra Molecular
• Takara Bio
• Tecan Group
• Thermo Fisher

Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 407 pages

Contents

I. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
  1. Major Factors Affecting Market Penetration of Microbiology Instrumentation
  2. Traditional Practices
  3. Technological Challenges
  4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
  1. Urine
  2. Sterile Fluids: Blood, Serum, and CSF
  3. Throat Swabs and Respiratory Secretions
  4. Genital Secretions
  5. Stool
  6. Abscess/Wound
  7. Sputum
  8. Saliva
C. Test Applications
  1. Microbial Identification
  2. Antibiotic Susceptibility
  3. Urine Screening
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
  1. Multiple Purpose Microbiology Systems
  2. Specialized Microbiology Systems
  3. Molecular Diagnostic Systems
  4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
    a. DNA Sequencing
      Introduction
      Sequencing Methods
      Autoradiography
      The Human Genome Project
      Sequencing Automation
      Image Scanners
      Fluorescent Detection
      Gene Profiling
      Gene Expression
      Polymorphism Screening
      Protein Interaction Networks
    b. DNA And RNA Probe Technology
      Basic Principles
      Probe Preparation
      The DNA Probe Test
      Sample Preparation
      Hybridization
        Separation
        Detection/Measurement
      Test Formats
      Filter Hybridization
      Southern Blot
      Northern Blot
      In Situ Hybridization
      Others
      Labeling Techniques
      Amplification Methods
      Polymerase Chain Reaction
      Temperature Cyclers
      PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
      Strand Displacement Activation
      TMA
      Ligase Chain Reaction
      Branched DNA
      Hybridization Protection Assay
      Nucleic-Acid Sequence-Based Amplification
      Self-Sustained Sequence Replicase
      Others
      Ampliprobe
      CAR
      CAS
      CPT
      Dendritic Polymer Technology
      ISO-CR
      LAT
      Probe
      RAMP
      Repair Chain Reaction
      Rolling Circles
      Sequence Independent Gene Amplification
      Sequence Initiation Reaction
      SISPA
      Solid Phase Amplification
    c. Detection Technologies
      Radioactive Methods
      Overview
      Major Isotopes
      P-32
      S-35
      H-3
      I-125
      Non-Isotopic Methods
      Enzymatic Labels
      Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
      Fluorescence
      Chemiluminescence
      Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
   Liquid Transportation and Mixing
        Separation
        Reaction
        Detection
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

II. SPAIN

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/Lab Corp
Decode Genetics
Diadexus
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech/Leica
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Spain Laboratories Performing Microbiology Tests by Market Segment
Spain Hospital Laboratories Performing Microbiology Tests by Bed Size
Spain Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
Spain All Market Segments Microbiology Specimen Volume
Spain Hospital Laboratories Microbiology Specimen Volume
Spain Commercial/Private Laboratories Microbiology Specimen Volume
Spain Microbiology Test Volume by Market Segment
Spain Microbiology Test Volume by Application
Spain Microbial Identification Test Volume by Market Segment
Spain Urine Screening Test Volume by Market Segment
Spain Blood Culture Test Volume by Market Segment
Spain Antibiotic Susceptibility Test Volume by Market Segment
Spain Microbiology Consumables Market by Application
Spain Microbiology Consumables Market by Market Segment
Spain Microbial Identification Consumables Sales by Market Segment
Spain Blood Culture Consumables Sales by Market Segment
Spain Antibiotic Susceptibility Consumables Sales by Market Segment
Spain Urine Screening Consumables Sales by Market Segment
Spain All Market Segments Infectious Disease Test Volume Forecast by Assay
Spain All Market Segments Infectious Disease Diagnostics Market Forecast by Test
Spain Infectious Disease Blood Screening NAT Volume Forecast by Assay
Spain Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Spain HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
Spain Chlamydia Testing Market Diagnostics Sales by Major Supplier
Spain CMV Testing Market Diagnostics Sales by Major Supplier
Spain Hepatitis Testing Market Diagnostics Sales by Major Supplier
Spain Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Spain Herpes Testing Market Diagnostics Sales by Major Supplier
Spain Influenza Testing Market Diagnostics Sales by Major Supplier
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Spain Meningitis Testing Market Diagnostics Sales by Major Supplier
Spain Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Spain Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Spain RSV Testing Market Diagnostics Sales by Major Supplier
Spain Rotavirus Testing Market Diagnostics Sales by Major Supplier
Spain Rubella Testing Market Diagnostics Sales by Major Supplier
Spain Septicemia Testing Market Diagnostics Sales by Major Supplier
Spain Streptococci Testing Market Diagnostics Sales by Major Supplier
Spain Syphilis Testing Market Diagnostics Sales by Major Supplier
Spain Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Spain Trichomonas Testing Market Diagnostics Sales by Major Supplier
Spain Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Spain Molecular Diagnostics Market Sales and Shares of Major Suppliers